United States Latanoprost Market Report 2017

January 2017 | 108 pages | ID: U95D40049F9EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Latanoprost

Revenue, means the sales value of Latanoprost

This report studies sales (consumption) of Latanoprost in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• Teva Pharmaceuticals
• Greenstone
• Novartis
• Mylan
• Taj Pharmaceuticals
• Apotex
• Sun Pharma
• Squibb
• Allergan Inc.
• Alcon Laboratories Inc.
• Bedford Laboratories
• Takeda

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Injection Liquid
• Freeze-dried Powder

Split by applications, this report focuses on sales, market share and growth rate of Latanoprost in each application, can be divided into

• Hospital Use
• Clinics
• Household

Contents

United States Latanoprost Market Report 2017

1 LATANOPROST OVERVIEW

1.1 Product Overview and Scope of Latanoprost
1.2 Classification of Latanoprost
  1.2.1 Injection Liquid
  1.2.2 Freeze-dried Powder
1.3 Application of Latanoprost
  1.3.1 Hospital Use
  1.3.2 Clinics
  1.3.3 Household
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Latanoprost (2011-2021)
  1.4.1 United States Latanoprost Sales and Growth Rate (2011-2021)
  1.4.2 United States Latanoprost Revenue and Growth Rate (2011-2021)

2 UNITED STATES LATANOPROST COMPETITION BY MANUFACTURERS

2.1 United States Latanoprost Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Latanoprost Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Latanoprost Average Price by Manufactures (2015 and 2016)
2.4 Latanoprost Market Competitive Situation and Trends
  2.4.1 Latanoprost Market Concentration Rate
  2.4.2 Latanoprost Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES LATANOPROST SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Latanoprost Sales and Market Share by States (2011-2016)
3.2 United States Latanoprost Revenue and Market Share by States (2011-2016)
3.3 United States Latanoprost Price by States (2011-2016)

4 UNITED STATES LATANOPROST SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Latanoprost Sales and Market Share by Type (2011-2016)
4.2 United States Latanoprost Revenue and Market Share by Type (2011-2016)
4.3 United States Latanoprost Price by Type (2011-2016)
4.4 United States Latanoprost Sales Growth Rate by Type (2011-2016)

5 UNITED STATES LATANOPROST SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Latanoprost Sales and Market Share by Application (2011-2016)
5.2 United States Latanoprost Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES LATANOPROST MANUFACTURERS PROFILES/ANALYSIS

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Latanoprost Product Type, Application and Specification
    6.1.2.1 Injection Liquid
    6.1.2.2 Freeze-dried Powder
  6.1.3 Pfizer Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Teva Pharmaceuticals
  6.2.2 Latanoprost Product Type, Application and Specification
    6.2.2.1 Injection Liquid
    6.2.2.2 Freeze-dried Powder
  6.2.3 Teva Pharmaceuticals Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Greenstone
  6.3.2 Latanoprost Product Type, Application and Specification
    6.3.2.1 Injection Liquid
    6.3.2.2 Freeze-dried Powder
  6.3.3 Greenstone Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Novartis
  6.4.2 Latanoprost Product Type, Application and Specification
    6.4.2.1 Injection Liquid
    6.4.2.2 Freeze-dried Powder
  6.4.3 Novartis Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Mylan
  6.5.2 Latanoprost Product Type, Application and Specification
    6.5.2.1 Injection Liquid
    6.5.2.2 Freeze-dried Powder
  6.5.3 Mylan Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Taj Pharmaceuticals
  6.6.2 Latanoprost Product Type, Application and Specification
    6.6.2.1 Injection Liquid
    6.6.2.2 Freeze-dried Powder
  6.6.3 Taj Pharmaceuticals Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Apotex
  6.7.2 Latanoprost Product Type, Application and Specification
    6.7.2.1 Injection Liquid
    6.7.2.2 Freeze-dried Powder
  6.7.3 Apotex Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Sun Pharma
  6.8.2 Latanoprost Product Type, Application and Specification
    6.8.2.1 Injection Liquid
    6.8.2.2 Freeze-dried Powder
  6.8.3 Sun Pharma Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Squibb
  6.9.2 Latanoprost Product Type, Application and Specification
    6.9.2.1 Injection Liquid
    6.9.2.2 Freeze-dried Powder
  6.9.3 Squibb Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Allergan Inc.
  6.10.2 Latanoprost Product Type, Application and Specification
    6.10.2.1 Injection Liquid
    6.10.2.2 Freeze-dried Powder
  6.10.3 Allergan Inc. Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Alcon Laboratories Inc.
6.12 Bedford Laboratories
6.13 Takeda

7 LATANOPROST MANUFACTURING COST ANALYSIS

7.1 Latanoprost Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Latanoprost

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Latanoprost Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Latanoprost Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LATANOPROST MARKET FORECAST (2016-2021)

11.1 United States Latanoprost Sales, Revenue Forecast (2016-2021)
11.2 United States Latanoprost Sales Forecast by Type (2016-2021)
11.3 United States Latanoprost Sales Forecast by Application (2016-2021)
11.4 Latanoprost Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Latanoprost
Table Classification of Latanoprost
Figure United States Sales Market Share of Latanoprost by Type in 2015
Figure Injection Liquid Picture
Figure Freeze-dried Powder Picture
Table Application of Latanoprost
Figure United States Sales Market Share of Latanoprost by Application in 2015
Figure Hospital Use Examples
Figure Clinics Examples
Figure Household Examples
Figure United States Latanoprost Sales and Growth Rate (2011-2021)
Figure United States Latanoprost Revenue and Growth Rate (2011-2021)
Table United States Latanoprost Sales of Key Manufacturers (2015 and 2016)
Table United States Latanoprost Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Latanoprost Sales Share by Manufacturers
Figure 2016 Latanoprost Sales Share by Manufacturers
Table United States Latanoprost Revenue by Manufacturers (2015 and 2016)
Table United States Latanoprost Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Latanoprost Revenue Share by Manufacturers
Table 2016 United States Latanoprost Revenue Share by Manufacturers
Table United States Market Latanoprost Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Latanoprost Average Price of Key Manufacturers in 2015
Figure Latanoprost Market Share of Top 3 Manufacturers
Figure Latanoprost Market Share of Top 5 Manufacturers
Table United States Latanoprost Sales by States (2011-2016)
Table United States Latanoprost Sales Share by States (2011-2016)
Figure United States Latanoprost Sales Market Share by States in 2015
Table United States Latanoprost Revenue and Market Share by States (2011-2016)
Table United States Latanoprost Revenue Share by States (2011-2016)
Figure Revenue Market Share of Latanoprost by States (2011-2016)
Table United States Latanoprost Price by States (2011-2016)
Table United States Latanoprost Sales by Type (2011-2016)
Table United States Latanoprost Sales Share by Type (2011-2016)
Figure United States Latanoprost Sales Market Share by Type in 2015
Table United States Latanoprost Revenue and Market Share by Type (2011-2016)
Table United States Latanoprost Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Latanoprost by Type (2011-2016)
Table United States Latanoprost Price by Type (2011-2016)
Figure United States Latanoprost Sales Growth Rate by Type (2011-2016)
Table United States Latanoprost Sales by Application (2011-2016)
Table United States Latanoprost Sales Market Share by Application (2011-2016)
Figure United States Latanoprost Sales Market Share by Application in 2015
Table United States Latanoprost Sales Growth Rate by Application (2011-2016)
Figure United States Latanoprost Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Latanoprost Sales Market Share (2011-2016)
Table Teva Pharmaceuticals Basic Information List
Table Teva Pharmaceuticals Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceuticals Latanoprost Sales Market Share (2011-2016)
Table Greenstone Basic Information List
Table Greenstone Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Greenstone Latanoprost Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Latanoprost Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Latanoprost Sales Market Share (2011-2016)
Table Taj Pharmaceuticals Basic Information List
Table Taj Pharmaceuticals Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Taj Pharmaceuticals Latanoprost Sales Market Share (2011-2016)
Table Apotex Basic Information List
Table Apotex Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Apotex Latanoprost Sales Market Share (2011-2016)
Table Sun Pharma Basic Information List
Table Sun Pharma Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharma Latanoprost Sales Market Share (2011-2016)
Table Squibb Basic Information List
Table Squibb Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Squibb Latanoprost Sales Market Share (2011-2016)
Table Allergan Inc. Basic Information List
Table Allergan Inc. Latanoprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Inc. Latanoprost Sales Market Share (2011-2016)
Table Alcon Laboratories Inc. Basic Information List
Table Bedford Laboratories Basic Information List
Table Takeda Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Latanoprost
Figure Manufacturing Process Analysis of Latanoprost
Figure Latanoprost Industrial Chain Analysis
Table Raw Materials Sources of Latanoprost Major Manufacturers in 2015
Table Major Buyers of Latanoprost
Table Distributors/Traders List
Figure United States Latanoprost Production and Growth Rate Forecast (2016-2021)
Figure United States Latanoprost Revenue and Growth Rate Forecast (2016-2021)
Table United States Latanoprost Production Forecast by Type (2016-2021)
Table United States Latanoprost Consumption Forecast by Application (2016-2021)
Table United States Latanoprost Sales Forecast by States (2016-2021)
Table United States Latanoprost Sales Share Forecast by States (2016-2021)